METAVIA INC. Stock-Based Compensation
METAVIA INC. (MTVA) reported Stock-Based Compensation of $230.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- METAVIA INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $130.00K, a 17.12% increase year-over-year.
- METAVIA INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $100.00K, a 24.24% decline year-over-year.
- METAVIA INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $71.00K, a 55.63% decline year-over-year.
- METAVIA INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $97.00K, a 30.22% decline year-over-year.
- METAVIA INC. share-based payment arrangement, noncash expense for fiscal 2025 was $411.00K, a 23.61% decline from fiscal 2024.
- METAVIA INC. share-based payment arrangement, noncash expense for fiscal 2024 was $538.00K, a 142.34% increase from fiscal 2023.
- METAVIA INC. share-based payment arrangement, noncash expense for fiscal 2023 was $222.00K, a 74.00% decline from fiscal 2022.
- METAVIA INC. share-based payment arrangement, noncash expense for fiscal 2022 was $854.00K, a 29.00% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $130.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $230.00K 10-Q · filed 2026-08-06 | $301.00K derived: sum of 3 quarters · filed 2026-08-06 | $398.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2026-03-31 | $100.00K 10-Q · filed 2026-05-14 | $171.00K derived: sum of 2 quarters · filed 2026-05-14 | $268.00K derived: sum of 3 quarters · filed 2026-05-14 | $379.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $168.00K derived: sum of 2 quarters · filed 2026-03-26 | $279.00K derived: sum of 3 quarters · filed 2026-08-06 | $411.00K 10-K · filed 2026-03-26 | |||
| 2025-09-30 | $97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $208.00K derived: sum of 2 quarters · filed 2026-08-06 | $340.00K 10-Q · filed 2025-11-06 | $500.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-06-30 | $111.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $243.00K 10-Q · filed 2026-08-06 | $403.00K derived: sum of 3 quarters · filed 2026-08-06 | $542.00K derived: sum of 4 quarters · filed 2026-08-06 | |||
| 2025-03-31 | $132.00K 10-Q · filed 2026-05-14 | $292.00K derived: sum of 2 quarters · filed 2026-05-14 | $431.00K derived: sum of 3 quarters · filed 2026-05-14 | $565.00K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $299.00K derived: sum of 2 quarters · filed 2026-03-26 | $433.00K derived: sum of 3 quarters · filed 2026-03-26 | $538.00K 10-K · filed 2026-03-26 | |||
| 2024-09-30 | $139.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $273.00K derived: sum of 2 quarters · filed 2025-11-06 | $378.00K 10-Q · filed 2025-11-06 | $478.00K derived: sum of 4 quarters · filed 2025-11-06 | |||
| 2024-06-30 | $134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $239.00K 10-Q · filed 2025-08-07 | $339.00K derived: sum of 3 quarters · filed 2025-08-07 | $511.00K derived: sum of 4 quarters · filed 2025-08-07 | |||
| 2024-03-31 | $105.00K 10-Q · filed 2025-05-14 | $205.00K derived: sum of 2 quarters · filed 2025-05-14 | $377.00K derived: sum of 3 quarters · filed 2025-05-14 | $401.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $272.00K derived: sum of 2 quarters · filed 2025-03-20 | $296.00K derived: sum of 3 quarters · filed 2025-03-20 | $222.00K 10-K · filed 2025-03-20 | |||
| 2023-09-30 | $172.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $196.00K derived: sum of 2 quarters · filed 2024-11-07 | $122.00K 10-Q · filed 2024-11-07 | $340.00K derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$50.00K 10-Q · filed 2024-08-14 | $168.00K derived: sum of 3 quarters · filed 2024-08-14 | $386.00K derived: sum of 4 quarters · filed 2024-08-14 | |||
| 2023-03-31 | -$74.00K 10-Q · filed 2024-05-09 | $144.00K derived: sum of 2 quarters · filed 2024-05-09 | $362.00K derived: sum of 3 quarters · filed 2024-05-09 | $573.00K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $218.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $436.00K derived: sum of 2 quarters · filed 2024-03-28 | $647.00K derived: sum of 3 quarters · filed 2024-03-28 | $854.00K 10-K · filed 2024-03-28 | |||
| 2022-09-30 | $218.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $429.00K derived: sum of 2 quarters · filed 2023-11-13 | $636.00K 10-Q · filed 2023-11-13 | $824.00K derived: sum of 4 quarters · filed 2023-11-13 | |||
| 2022-06-30 | $211.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $418.00K 10-Q · filed 2023-08-09 | $606.00K derived: sum of 3 quarters · filed 2023-08-09 | $713.00K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | $207.00K 10-Q · filed 2023-05-12 | $395.00K derived: sum of 2 quarters · filed 2023-05-12 | $502.00K derived: sum of 3 quarters · filed 2023-05-12 | $682.00K derived: sum of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $295.00K derived: sum of 2 quarters · filed 2023-03-30 | $475.00K derived: sum of 3 quarters · filed 2023-03-30 | $662.00K 10-K · filed 2023-03-30 | |||
| 2021-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $287.00K derived: sum of 2 quarters · filed 2022-11-14 | $474.00K 10-Q · filed 2022-11-14 | $634.00K derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $367.00K 10-Q · filed 2022-08-12 | $527.00K derived: sum of 3 quarters · filed 2022-08-12 | $736.00K derived: sum of 4 quarters · filed 2022-08-12 | |||
| 2021-03-31 | $187.00K 10-Q · filed 2022-05-13 | $347.00K derived: sum of 2 quarters · filed 2022-05-13 | $556.00K derived: sum of 3 quarters · filed 2022-05-13 | $727.00K derived: sum of 4 quarters · filed 2022-05-13 | |||
| 2020-12-31 | $160.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $369.00K derived: sum of 2 quarters · filed 2022-03-31 | $540.00K derived: sum of 3 quarters · filed 2022-03-31 | $699.00K 10-K · filed 2022-03-31 | |||
| 2020-09-30 | $209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $380.00K derived: sum of 2 quarters · filed 2021-11-15 | $539.00K 10-Q · filed 2021-11-15 | $464.00K derived: sum of 4 quarters · filed 2021-11-15 | |||
| 2020-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $330.00K 10-Q · filed 2021-08-16 | $255.00K derived: sum of 3 quarters · filed 2021-08-16 | $309.00K derived: sum of 4 quarters · filed 2021-08-16 | |||
| 2020-03-31 | $159.00K 10-Q · filed 2021-05-17 | $84.00K derived: sum of 2 quarters · filed 2021-05-17 | $138.00K derived: sum of 3 quarters · filed 2021-05-17 | $217.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | -$21.00K derived: sum of 2 quarters · filed 2021-04-15 | $58.00K derived: sum of 3 quarters · filed 2021-04-15 | $118.00K 10-K · filed 2021-04-15 | |||
| 2019-09-30 | $54.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $133.00K derived: sum of 2 quarters · filed 2020-11-13 | $193.00K 10-Q · filed 2020-11-13 | $1.35M 10-Q · filed 2019-11-08 | $768.00K derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $139.00K 10-Q · filed 2020-08-11 | $911.00K 10-Q · filed 2019-08-09 | $714.00K derived: sum of 3 quarters · filed 2020-08-11 | $2.34M derived: sum of 4 quarters · filed 2020-08-11 | ||
| 2019-03-31 | $60.00K 10-Q · filed 2020-05-20 | $473.00K 10-Q · filed 2019-05-09 | $635.00K derived: sum of 2 quarters · filed 2020-05-20 | $2.26M derived: sum of 3 quarters · filed 2020-05-20 | $3.17M derived: sum of 4 quarters · filed 2020-05-20 | ||
| 2018-12-31 | $575.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $2.20M derived: sum of 2 quarters · filed 2019-11-08 | $3.11M derived: sum of 3 quarters · filed 2019-11-08 | $4.13M 10-K · filed 2019-03-18 | |||
| 2018-09-30 | $1.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $2.54M derived: sum of 2 quarters · filed 2019-11-08 | $3.56M 10-Q · filed 2019-11-08 | $4.29M derived: sum of 4 quarters · filed 2019-11-08 | |||
| 2018-06-30 | $909.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $1.93M 10-Q · filed 2019-08-09 | $2.67M derived: sum of 3 quarters · filed 2019-08-09 | $3.40M derived: sum of 4 quarters · filed 2019-08-09 | |||
| 2018-03-31 | $1.02M 10-Q · filed 2019-05-09 | $1.76M derived: sum of 2 quarters · filed 2019-05-09 | $2.49M derived: sum of 3 quarters · filed 2019-05-09 | $5.46M derived: sum of 4 quarters · filed 2019-05-09 | |||
| 2017-12-31 | $738.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.47M derived: sum of 2 quarters · filed 2019-03-18 | $4.44M derived: sum of 3 quarters · filed 2019-03-18 | $5.27M 10-K · filed 2019-03-18 | |||
| 2017-09-30 | $736.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.70M derived: sum of 2 quarters · filed 2018-11-08 | $4.54M 10-Q · filed 2018-11-08 | $5.47M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $3.80M 10-Q · filed 2018-08-14 | $4.73M derived: sum of 3 quarters · filed 2019-03-18 | $5.30M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2017-03-31 | $836.00K 10-Q · filed 2018-05-08 | $1.77M derived: sum of 2 quarters · filed 2019-03-18 | $2.34M derived: sum of 3 quarters · filed 2019-03-18 | $2.43M derived: sum of 4 quarters · filed 2019-03-18 | |||
| 2016-12-31 | $933.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $1.50M derived: sum of 2 quarters · filed 2019-03-18 | $1.59M derived: sum of 3 quarters · filed 2019-03-18 | $1.72M 10-K · filed 2019-03-18 | |||
| 2016-09-30 | $567.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $662.00K derived: sum of 2 quarters · filed 2017-11-13 | $785.00K 10-Q · filed 2017-11-13 | $888.00K derived: sum of 4 quarters · filed 2018-03-20 | |||
| 2016-06-30 | $95.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $218.00K 10-Q · filed 2017-08-14 | $321.00K derived: sum of 3 quarters · filed 2018-03-20 | $415.00K derived: sum of 4 quarters · filed 2018-03-20 | |||
| 2016-03-31 | $123.00K 10-Q · filed 2017-05-10 | $226.00K derived: sum of 2 quarters · filed 2018-03-20 | $320.00K derived: sum of 3 quarters · filed 2018-03-20 | ||||
| 2015-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $197.00K derived: sum of 2 quarters · filed 2018-03-20 | $284.00K 10-K · filed 2018-03-20 | ||||
| 2015-09-30 | $94.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | $181.00K 10-Q · filed 2016-11-02 | |||||
| 2015-06-30 | $87.00K 10-Q · filed 2016-09-14 | ||||||
| 2014-12-31 | $53.00K 10-K · filed 2017-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |